News Sentiment

TLX sentiment intelligence

Telix Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 33 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 14.50 Week of 19 Jun 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 33

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+6.6% over one week, +8.9% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Is Telix Pharmaceuticals (ASX:TLX) the ASX Mid-Cap Health Leader?

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction 6.6% Price confirming higher
Trend fit Trend active 8.9% over four weeks
Fair value -13.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 26
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 33
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 5
simplywall.st 4
Kalkine 3
The Motley Fool Australia 2
Kalkine Media 1
Insider Monkey 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 24
Deals and strategy 2
Analyst action 2
Earnings 2
Guidance 2
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 33